5 Thalassaemia: clinical management
- 1 March 1998
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 11 (1), 147-162
- https://doi.org/10.1016/s0950-3536(98)80073-5
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Successful Use of Hydroxyurea in β-Thalassemia MajorNew England Journal of Medicine, 1997
- Evaluation of a new method of administration of the iron chelating agent deferoxamineThe Journal of Pediatrics, 1997
- A novel delivery system for continuous desferrioxamine infusion in transfusional iron overloadBritish Journal of Haematology, 1996
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia majorAmerican Journal of Hematology, 1993
- Long‐term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trialBritish Journal of Haematology, 1992
- Development of iron-chelating agents for clinical use [editorial; comment]Blood, 1992
- Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia MajorNew England Journal of Medicine, 1990
- RAPID DESENSITISATION FOR DESFERRIOXAMINE ANAPHYLACTOID REACTIONSThe Lancet, 1983
- Magnetic-Susceptibility Measurement of Human Iron StoresNew England Journal of Medicine, 1982